Aarey Drugs Pharmaceuticals Ltd vs Beryl Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 88.97 as of 05 May 15:30 . The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 8.3 on March 2021 to 23.9 on March 2025 . This represents a CAGR of 23.56% over 5 yearsThe P/E Ratio of Beryl Drugs Ltd changed from 14.1 on March 2021 to 18.5 on March 2025 . This represents a CAGR of 5.58% over 5 years The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 54.25 crore on March 2021 to ₹ 95.58 crore on March 2025 . This represents a CAGR of 11.99% over 5 yearsThe Market Cap of Beryl Drugs Ltd changed from ₹ 3.35 crore on March 2021 to ₹ 10.68 crore on March 2025 . This represents a CAGR of 26.10% over 5 years The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 100.61 crore as compare to the Sep '25 revenue of ₹ 84.95 crore. This represent the growth of 18.43% The revenue of Beryl Drugs Ltd for the Dec '25 is ₹ 3.85 crore as compare to the Sep '25 revenue of ₹ 5.16 crore. This represent the decline of -25.39% The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 2.67 crore as compare to the Sep '25 ebitda of ₹ 3.44 crore. This represent the decline of -22.38% The ebitda of Beryl Drugs Ltd for the Dec '25 is ₹ -0.2 crore as compare to the Sep '25 ebitda of ₹ 0.73 crore. This represent the decline of -127% The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 1.24 crore to ₹ 0.57 crore over 7 quarters. This represents a CAGR of -35.86% The net profit of Beryl Drugs Ltd changed from ₹ 0.37 crore to ₹ -0.17 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Beryl Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company.
Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Beryl Drugs Ltd

Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993.
The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993.
The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally.
It offers I.V.fluids, and a range of small and large volume injectables.
It provides a range of eye/ear drops, veterinary products, and injections.

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Beryl Drugs Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Beryl Drugs Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 252 Cr while Market cap of Beryl Drugs Ltd is 11 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Beryl Drugs Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Beryl Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Beryl Drugs Ltd?

As of May 5, 2026, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹88.97. On the other hand, Beryl Drugs Ltd stock price is INR ₹21.75.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Beryl Drugs Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Beryl Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.